Please select a region
Manage Consent Preferences
Cookie Details
Strictly Functional Cookie
Analytics Cookie
Targeting Cookie
Back
Analytics Cookies
x
Cookies List
Our site is undergoing a scheduled maintenance from 30th December 2020 to 3rd January 2021 and some functionalities will not be available at this time
Loading your cart..
-
Products
Products
-
Services
Services
-
-
Challenges
Challenges
-
Reducing Total Cost of Ownership
Solving the Challenge of High pH Injectable Drug ProductsClick HerePackaging Solutions for Sensitive Molecules
Solving the Challenge of Single-Use Large-Volume Delivery for Patient Self-Injection
-
-
Support
Support
-
Fill-Finish Support ServicesThrough our Integrated Solutions program and collaborations with equipment manufacturers and Contract Manufacturing Organizations (CMOs), West can assist drug developers with fill-finish services.Fill-Finish Support ServicesKnowledge CenterThe West Knowledge Center provides scientific insight and more detailed technical information on key areas of expertise featuring technical reports, bulletins and science posters.Knowledge Center
-
Services
Challenges

Solving the Challenge of High pH Injectable Drug Products
Click Here

Solving the Challenge of Single-Use Large-Volume Delivery for Patient Self-Injection
Support
Fill-Finish Support Services
Through our Integrated Solutions program and collaborations with equipment manufacturers and Contract Manufacturing Organizations (CMOs), West can assist drug developers with fill-finish services.
Fill-Finish Support Services
Knowledge Center
The West Knowledge Center provides scientific insight and more detailed technical information on key areas of expertise featuring technical reports, bulletins and science posters.
Knowledge Center
Latest Post
December 23, 2020
Container Closure Integrity Evaluation for Cell and Gene Therapies
With the growth of gene and cell therapies, there is an increased need to characterize container closure systems (CCS) at the low temperatures experienced during their lifecycles: ultra-low (-80°C) for genes and cryogenic (-180°C) for cells. West’s Integrated Solutions platform includes the state-of-the-art container closure integrity (CCI) capabilities needed for these therapies.

Olga Laskina, PhD.
Sr. Technical Account Specialist, TCS NA
Previous Posts

October 09, 2020
Evaluation of Container Closure Integrity of Vial-Based Primary Packaging Systems

Candice Sun
Specialist, Scientific Affairs, CN

August 06, 2020
West's Integrated Solutions - Reducing Risks

Jia Min Boo
Technical Account Specialist, TCS, Jurong

July 13, 2020
Consistent Crimp, Consistent CCI

Gabrielle Gehron
Associate Technical Account Specialist, TCS

June 08, 2020
West’s Integrated Solutions – Container Closure Integrity

James McCaw
Manager, Lab, CCI Technology

March 23, 2020
Dynamic Sealing Performance of Container Closure Systems at Low Temperature

Qingyu Zeng Ph.D.
Fellow Scientist and Technical Director, Scientific Insights Lab

December 09, 2019
Evaluation of Container Systems with Residual Seal Force (RSF)

Mary Tan
Specialist, Scientific Affairs, Singapore, Jurong
Load more
Loading...